A Study to Assess the Efficacy and Safety of MNK-1411 in Duchenne Muscular Dystrophy
Clinical trial NCT03400852 · TERMINATED
Trial details
- NCT number
- NCT03400852
- Sponsor
- Mallinckrodt ARD LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-27
- Primary completion
- 2020-02-25
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.